Clark Health Communications (CHC) has appointed Sarah Newman as its first full-time team member in the role of account director.
Newman will help manage Clark Health Communications’ business in women’s health and alcohol dependence, which includes the Communiqué Award-winning campaign for Lundbeck’s Selincro (nalmefene).
She gained experience in PR, medical education and corporate communications during her time at Galliard where she was also account director. Prior to that she was an account manager at first Ruder Finn, then Red Consultancy.
“I’m thrilled to be joining at such an exciting time for CHC and to be part of developing the business and our team at this early stage,” she said.
CHC was founded in 2011 by Jeremy Clark, who had previously led teams at Cohn & Wolfe and Huntsworth Health. The last three years have seen the new agency grow rapidly, with clients in women’s health, Parkinson’s disease and alcohol dependence.
The core team, now including Newman, is based in London. It is supported by a network of specialist communicators ranging from expert strategic advisors and medical writers to creative designers and meeting coordinators based around the UK.
“Ultimately, our goal is to maximise the role of communications in health and medicine, and as a result, to make clients think differently about communications and communications agencies,” said Clark.
In addition to its victory in the 2014 Communiqué Award for Excellence in Product Communications for its work with Lundbeck, CHC was also a finalist for its entry in the Excellence in Professional Education Programmes category for its work with Bayer.